ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

40.16 +0.21 (+0.54%)

Streaming Delayed Price Updated: 12:10 PM EDT, Sep 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	236,123
Open	40.20
Bid (Size)	40.13 (100)
Ask (Size)	40.20 (300)
Prev. Close	39.95
Today's Range	39.58 - 41.48
52wk Range	23.23 - 42.68
Shares Outstanding	48,390,394
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

IDEAYA Biosciences (NASDAQ:IDYA) Displays Perfect Technical Strength and Breakout Setup ↗

August 10, 2026

Via Chartmill

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit ↗

May 26, 2026

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit,...

Via MarketBeat

Performance

YTD	+18.7%	+18.7%
1 Month	+13.5%	+13.5%
3 Month	+44.1%	+44.1%
6 Month	+17.1%	+17.1%
1 Year	+57.6%	+57.6%

More News

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing ↗

May 25, 2026

Via MarketBeat

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗

May 18, 2026

Via MarketBeat

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology

May 14, 2026

From USA News Group

Via GlobeNewswire

Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

April 13, 2026

Via Benzinga

Get insights into the top gainers and losers of Friday's after-hours session. ↗

April 10, 2026

Via Chartmill

A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗

March 15, 2026

Via The Motley Fool

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

IDEAYA Biosciences Inc (NASDAQ:IDYA) Shows Strong Technical Setup for Potential Breakout ↗

December 22, 2025

Via Chartmill

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 21, 2025

Via Benzinga

Buying IDEAYA Might Be The Wrong IDYA Right Now ↗

September 16, 2025

Via Benzinga

Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 29, 2025

Via Benzinga

IDEAYA (IDYA) Q2 Net Loss Improves 27% ↗

August 05, 2025

Via The Motley Fool

This Royal Caribbean Cruises Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗

July 22, 2025

Via Benzinga

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

June 26, 2025

Via Benzinga

This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 26, 2025

Via Benzinga

Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗

November 15, 2024

Via Benzinga

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

November 11, 2024

From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Via Business Wire

This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 05, 2024

Via Benzinga

Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate ↗

September 23, 2024

Via Benzinga

Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 10, 2024

Via Benzinga

IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 ↗

August 06, 2024

Via InvestorPlace

Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗

August 03, 2024

Via Talk Markets

Frequently Asked Questions

Is IDEAYA Biosciences, Inc. - Common Stock publicly traded?

Yes, IDEAYA Biosciences, Inc. - Common Stock is publicly traded.

What exchange does IDEAYA Biosciences, Inc. - Common Stock trade on?

IDEAYA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for IDEAYA Biosciences, Inc. - Common Stock?

The ticker symbol for IDEAYA Biosciences, Inc. - Common Stock is IDYA on the Nasdaq Stock Market

What is the current price of IDEAYA Biosciences, Inc. - Common Stock?

The current price of IDEAYA Biosciences, Inc. - Common Stock is 40.16

When was IDEAYA Biosciences, Inc. - Common Stock last traded?

The last trade of IDEAYA Biosciences, Inc. - Common Stock was at 09/02/26 12:10 PM ET

What is the market capitalization of IDEAYA Biosciences, Inc. - Common Stock?

The market capitalization of IDEAYA Biosciences, Inc. - Common Stock is 1.94B

How many shares of IDEAYA Biosciences, Inc. - Common Stock are outstanding?

IDEAYA Biosciences, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.